ArticleThe American journal of tropical medicine and hygiene2025
Access and Awareness of Morbidity Management and Disability Prevention for Lower Limb Lymphatic Filariasis in Post-Mass Drug Administration Districts in Southern India.
Article in The American journal of tropical medicine and hygiene, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The Global Program to Eliminate Lymphatic Filariasis (LF) aims to eliminate transmission through mass drug administration (MDA) and manage LF disease through morbidity management and disability prevention (MMDP). In this study, surveys on awareness and access to MMDP and quality of life (QoL) among lower limb LF cases in a censused population in two post-MDA districts in Tamil Nadu were conducted. The prevalence of lower limb LF was 0.11% (165/147,871), with 57.6% in reversible stage 1 and 2 categories, 36.4% in stage 3, and 6.1% in stage 4 and above. Among them, 22.4% reported health worker visits, 11.5% were aware of MMDP camps, and 36.4% received MMDP kits. The life activity (mean score: 48.5; SD: 27.3) and mobility (41.2; 24.2) domains exhibited the poorest QoL scores. In post-MDA districts, strengthening the reach and awareness of MMDP programs in communities, especially for early, reversible stages, is pivotal to halting disease progression and improving QoL.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.